# Teradata Corp: financial statements, quarterly

TDC · NYSE · CIK 816761 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tdc.md) · [Financials](/companies/tdc/financials.md) · [Filings](/companies/tdc/filings.md) · [Insiders](/companies/tdc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tdc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [438](/filings/0000816761-24-000162.md) | [457 d](/filings/0001628280-26-012671.md) | [465](/filings/0000816761-25-000108.md) | [436](/filings/0000816761-25-000182.md) | [440](/filings/0001628280-25-049313.md) | [409 d](/filings/0001628280-26-012671.md) | [418](/filings/0001628280-26-031053.md) | [408](/filings/0001628280-26-053103.md) | [416](/filings/0001628280-25-049313.md) | [421 d](/filings/0001628280-26-012671.md) | [444](/filings/0001628280-26-031053.md) | [410](/filings/0001628280-26-053103.md) |
| Cost of revenue | $m | [179](/filings/0000816761-24-000162.md) | [179 d](/filings/0001628280-26-012671.md) | [181](/filings/0000816761-25-000108.md) | [171](/filings/0000816761-25-000182.md) | [174](/filings/0001628280-25-049313.md) | [166 d](/filings/0001628280-26-012671.md) | [170](/filings/0001628280-26-031053.md) | [178](/filings/0001628280-26-053103.md) | [163](/filings/0001628280-25-049313.md) | [165 d](/filings/0001628280-26-012671.md) | [168](/filings/0001628280-26-031053.md) | [167](/filings/0001628280-26-053103.md) |
| Gross profit | $m | [259](/filings/0000816761-24-000162.md) | [278 d](/filings/0001628280-26-012671.md) | [284](/filings/0000816761-25-000108.md) | [265](/filings/0000816761-25-000182.md) | [266](/filings/0001628280-25-049313.md) | [243 d](/filings/0001628280-26-012671.md) | [248](/filings/0001628280-26-031053.md) | [230](/filings/0001628280-26-053103.md) | [253](/filings/0001628280-25-049313.md) | [256 d](/filings/0001628280-26-012671.md) | [276](/filings/0001628280-26-031053.md) | [243](/filings/0001628280-26-053103.md) |
| Research and development | $m | [76.0](/filings/0000816761-24-000162.md) | [72.0 d](/filings/0001628280-26-012671.md) | [75.0](/filings/0000816761-25-000108.md) | [68.0](/filings/0000816761-25-000182.md) | [73.0](/filings/0001628280-25-049313.md) | [68.0 d](/filings/0001628280-26-012671.md) | [66.0](/filings/0001628280-26-031053.md) | [71.0](/filings/0001628280-26-053103.md) | [70.0](/filings/0001628280-25-049313.md) | [73.0 d](/filings/0001628280-26-012671.md) | [72.0](/filings/0001628280-26-031053.md) | [75.0](/filings/0001628280-26-053103.md) |
| Selling, general and administrative | $m | [156](/filings/0000816761-24-000162.md) | [159 d](/filings/0001628280-26-012671.md) | [161](/filings/0000816761-25-000108.md) | [131](/filings/0000816761-25-000182.md) | [137](/filings/0001628280-25-049313.md) | [136 d](/filings/0001628280-26-012671.md) | [116](/filings/0001628280-26-031053.md) | [135](/filings/0001628280-26-053103.md) | [122](/filings/0001628280-25-049313.md) | [129 d](/filings/0001628280-26-012671.md) | [240](/filings/0001628280-26-031053.md) | [120](/filings/0001628280-26-053103.md) |
| Operating income | $m | [27.0](/filings/0000816761-24-000162.md) | [47.0 d](/filings/0001628280-26-012671.md) | [48.0](/filings/0000816761-25-000108.md) | [66.0](/filings/0000816761-25-000182.md) | [56.0](/filings/0001628280-25-049313.md) | [39.0 d](/filings/0001628280-26-012671.md) | [66.0](/filings/0001628280-26-031053.md) | [24.0](/filings/0001628280-26-053103.md) | [61.0](/filings/0001628280-25-049313.md) | [54.0 d](/filings/0001628280-26-012671.md) | [(36.0)](/filings/0001628280-26-031053.md) | [48.0](/filings/0001628280-26-053103.md) |
| Interest expense | $m | [8.0](/filings/0000816761-23-000025.md) | [8.0 d](/filings/0000816761-24-000023.md) | [8.0](/filings/0000816761-24-000098.md) | [7.0](/filings/0000816761-25-000182.md) | [7.0](/filings/0001628280-25-049313.md) | [7.0 d](/filings/0001628280-26-012671.md) | [7.0](/filings/0001628280-26-031053.md) | [6.0](/filings/0001628280-26-053103.md) | [7.0](/filings/0001628280-25-049313.md) | [6.0 d](/filings/0001628280-26-012671.md) | [6.0](/filings/0001628280-26-031053.md) | [6.0](/filings/0001628280-26-053103.md) |
| Income tax | $m | [1.0](/filings/0000816761-24-000162.md) | [29.0 d](/filings/0001628280-26-012671.md) | [12.0](/filings/0000816761-25-000108.md) | [18.0](/filings/0000816761-25-000182.md) | [15.0](/filings/0001628280-25-049313.md) | [5.0 d](/filings/0001628280-26-012671.md) | [14.0](/filings/0001628280-26-031053.md) | [4.0](/filings/0001628280-26-053103.md) | [14.0](/filings/0001628280-25-049313.md) | [16.0 d](/filings/0001628280-26-012671.md) | [102](/filings/0001628280-26-031053.md) | [1.0](/filings/0001628280-26-053103.md) |
| Net income | $m | [12.0](/filings/0000816761-24-000162.md) | [(7.0) d](/filings/0001628280-26-012671.md) | [20.0](/filings/0001628280-25-049313.md) | [37.0](/filings/0001628280-25-049313.md) | [32.0](/filings/0001628280-25-049313.md) | [25.0 d](/filings/0001628280-26-012671.md) | [44.0](/filings/0001628280-26-053103.md) | [9.0](/filings/0001628280-26-053103.md) | [40.0](/filings/0001628280-25-049313.md) | [37.0 d](/filings/0001628280-26-012671.md) | [335](/filings/0001628280-26-053103.md) | [46.0](/filings/0001628280-26-053103.md) |
| Diluted EPS | $ per share | [0.12](/filings/0000816761-24-000162.md) | not reported | [0.20](/filings/0000816761-25-000108.md) | [0.38](/filings/0000816761-25-000182.md) | [0.33](/filings/0001628280-25-049313.md) | not reported | [0.45](/filings/0001628280-26-031053.md) | [0.09](/filings/0001628280-26-053103.md) | [0.42](/filings/0001628280-25-049313.md) | not reported | [3.47](/filings/0001628280-26-031053.md) | [0.48](/filings/0001628280-26-053103.md) |
| Basic EPS | $ per share | [0.12](/filings/0000816761-24-000162.md) | not reported | [0.21](/filings/0000816761-25-000108.md) | [0.38](/filings/0000816761-25-000182.md) | [0.33](/filings/0001628280-25-049313.md) | not reported | [0.46](/filings/0001628280-26-031053.md) | [0.09](/filings/0001628280-26-053103.md) | [0.42](/filings/0001628280-25-049313.md) | not reported | [3.60](/filings/0001628280-26-031053.md) | [0.49](/filings/0001628280-26-053103.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [348](/filings/0000816761-23-000025.md) | [486](/filings/0001628280-26-012671.md) | [337](/filings/0000816761-24-000098.md) | [301](/filings/0000816761-24-000146.md) | [348](/filings/0000816761-24-000162.md) | [420](/filings/0001628280-26-012671.md) | [368](/filings/0000816761-25-000108.md) | [369](/filings/0000816761-25-000182.md) | [406](/filings/0001628280-25-049313.md) | [493](/filings/0001628280-26-053103.md) | [816](/filings/0001628280-26-031053.md) | [414](/filings/0001628280-26-053103.md) |
| Current assets | $m | [738](/filings/0000816761-23-000025.md) | [869](/filings/0000816761-25-000027.md) | [769](/filings/0000816761-24-000098.md) | [665](/filings/0000816761-24-000146.md) | [703](/filings/0000816761-24-000162.md) | [749](/filings/0001628280-26-012671.md) | [791](/filings/0000816761-25-000108.md) | [757](/filings/0000816761-25-000182.md) | [811](/filings/0001628280-25-049313.md) | [837](/filings/0001628280-26-053103.md) | [1,240](/filings/0001628280-26-031053.md) | [773](/filings/0001628280-26-053103.md) |
| Total assets | $m | [1,740](/filings/0000816761-23-000025.md) | [1,873](/filings/0000816761-25-000027.md) | [1,745](/filings/0000816761-24-000098.md) | [1,622](/filings/0000816761-24-000146.md) | [1,659](/filings/0000816761-24-000162.md) | [1,704](/filings/0001628280-26-012671.md) | [1,752](/filings/0000816761-25-000108.md) | [1,737](/filings/0000816761-25-000182.md) | [1,761](/filings/0001628280-25-049313.md) | [1,779](/filings/0001628280-26-053103.md) | [2,142](/filings/0001628280-26-031053.md) | [1,658](/filings/0001628280-26-053103.md) |
| Current liabilities | $m | [885](/filings/0000816761-23-000025.md) | [996](/filings/0000816761-25-000027.md) | [983](/filings/0000816761-24-000098.md) | [889](/filings/0000816761-24-000146.md) | [875](/filings/0000816761-24-000162.md) | [930](/filings/0001628280-26-012671.md) | [946](/filings/0000816761-25-000108.md) | [898](/filings/0000816761-25-000182.md) | [906](/filings/0001628280-25-049313.md) | [914](/filings/0001628280-26-053103.md) | [954](/filings/0001628280-26-031053.md) | [845](/filings/0001628280-26-053103.md) |
| Total liabilities | $m | [1,618](/filings/0000816761-23-000025.md) | [1,738](/filings/0000816761-25-000027.md) | [1,691](/filings/0000816761-24-000098.md) | [1,547](/filings/0000816761-24-000146.md) | [1,534](/filings/0000816761-24-000162.md) | [1,571](/filings/0001628280-26-012671.md) | [1,594](/filings/0000816761-25-000108.md) | [1,561](/filings/0000816761-25-000182.md) | [1,542](/filings/0001628280-25-049313.md) | [1,549](/filings/0001628280-26-053103.md) | [1,585](/filings/0001628280-26-031053.md) | [1,065](/filings/0001628280-26-053103.md) |
| Long-term debt | $m | [486](/filings/0000816761-23-000025.md) | [480](/filings/0000816761-25-000027.md) | [474](/filings/0000816761-24-000098.md) | [467](/filings/0000816761-24-000146.md) | [461](/filings/0000816761-24-000162.md) | [455](/filings/0001628280-26-012671.md) | [449](/filings/0000816761-25-000108.md) | [443](/filings/0000816761-25-000182.md) | [437](/filings/0001628280-25-049313.md) | [431](/filings/0001628280-26-053103.md) | [424](/filings/0001628280-26-031053.md) | [0.0](/filings/0001628280-26-053103.md) |
| Current portion of debt | $m | [12.0](/filings/0000816761-23-000025.md) | [19.0](/filings/0000816761-25-000027.md) | [25.0](/filings/0000816761-24-000098.md) | [25.0](/filings/0000816761-24-000146.md) | [25.0](/filings/0000816761-24-000162.md) | [25.0](/filings/0001628280-26-012671.md) | [25.0](/filings/0000816761-25-000108.md) | [25.0](/filings/0000816761-25-000182.md) | [25.0](/filings/0001628280-25-049313.md) | [25.0](/filings/0001628280-26-053103.md) | [25.0](/filings/0001628280-26-031053.md) | [0.0](/filings/0001628280-26-053103.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [122](/filings/0000816761-24-000162.md) | [135](/filings/0001628280-26-012671.md) | [54.0](/filings/0001628280-25-049313.md) | [75.0](/filings/0001628280-25-049313.md) | [125](/filings/0001628280-25-049313.md) | [133](/filings/0001628280-26-053103.md) | [158](/filings/0001628280-26-053103.md) | [176](/filings/0001628280-26-053103.md) | [219](/filings/0001628280-25-049313.md) | [230](/filings/0001628280-26-053103.md) | [557](/filings/0001628280-26-053103.md) | [593](/filings/0001628280-26-053103.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [41.0 d](/filings/0000816761-24-000162.md) | [176 d](/filings/0001628280-26-012671.md) | [27.0](/filings/0000816761-25-000108.md) | [43.0 d](/filings/0000816761-25-000182.md) | [77.0 d](/filings/0001628280-25-049313.md) | [156 d](/filings/0001628280-26-012671.md) | [8.0](/filings/0001628280-26-031053.md) | [43.0 d](/filings/0001628280-26-053103.md) | [94.0 d](/filings/0001628280-25-049313.md) | [160 d](/filings/0001628280-26-012671.md) | [401](/filings/0001628280-26-031053.md) | [106 d](/filings/0001628280-26-053103.md) |
| Capital expenditure | $m | [5.0 d](/filings/0000816761-24-000162.md) | [8.0 d](/filings/0001628280-26-012671.md) | [6.0](/filings/0000816761-25-000108.md) | [3.0 d](/filings/0000816761-25-000182.md) | [8.0 d](/filings/0001628280-25-049313.md) | [7.0 d](/filings/0001628280-26-012671.md) | [1.0](/filings/0001628280-26-031053.md) | [4.0 d](/filings/0001628280-26-053103.md) | [5.0 d](/filings/0001628280-25-049313.md) | [9.0 d](/filings/0001628280-26-012671.md) | [10.0](/filings/0001628280-26-031053.md) | [1.0 d](/filings/0001628280-26-053103.md) |
| Share repurchases | $m | [147 d](/filings/0000816761-24-000162.md) | [7.0 d](/filings/0001628280-26-012671.md) | [124](/filings/0000816761-25-000108.md) | [47.0 d](/filings/0000816761-25-000182.md) | [15.0 d](/filings/0001628280-25-049313.md) | [29.0 d](/filings/0001628280-26-012671.md) | [44.0](/filings/0001628280-26-031053.md) | [28.0 d](/filings/0001628280-26-053103.md) | [30.0 d](/filings/0001628280-25-049313.md) | [38.0 d](/filings/0001628280-26-012671.md) | [34.0](/filings/0001628280-26-031053.md) | [40.0 d](/filings/0001628280-26-053103.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [105](/filings/0000816761-23-000025.md) | [104](/filings/0000816761-24-000098.md) | [103](/filings/0000816761-24-000146.md) | [102](/filings/0000816761-24-000162.md) | [100](/filings/0000816761-25-000108.md) | [97.4](/filings/0000816761-25-000182.md) | [97.0](/filings/0001628280-25-049313.md) | [97.4](/filings/0001628280-26-031053.md) | [96.0](/filings/0001628280-26-053103.md) | [95.5](/filings/0001628280-25-049313.md) | [96.6](/filings/0001628280-26-031053.md) | [96.2](/filings/0001628280-26-053103.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 93,000,000 at 2026-07-24, from the cover of the [10-Q filed 2026-08-05](/filings/0001628280-26-053103.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.